CTS16 - Diagnostic Pitfalls in COVID-19

Speaker(s)

• 

  Corine Geurts van Kessel, MD PhD

  Clinical virologist
  Erasmus MC department of Viroscience

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides
• JH

  Jim Huggett

  University of Surrey

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Dana Wolf, MD

  Prof.
  Hadassah-Hebrew University Medical Center
  Jerusalem, Yerushalayim, Israel

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

CME Credits: Maximum of 1 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1 hours of MOC Credit

No CPE Credits

Learning Objectives:

• discuss the analytical performance and limitations of SARS-CoV-2 molecular detection
• describe when and how to use sample pooling for COVID-19 detection
• explain the pertinent antibodies to detect for COVID diagnostic

Presentations:

• 5:00am – 5:20am EDT

  Analytical Performance and Limitations of SARS-CoV-2 Molecular Detection –LGC, UK
  Jim Huggett – University of Surrey
• 5:20am – 5:40am EDT

  Sample Pooling for SARS-CoV-2 Detection – When and How?
  Dana Wolf, MD – Hadassah-Hebrew University Medical Center
• 5:40am – 6:00am EDT

  IgG, IgM and IgA: What Are the Pertinent Antibodies to Detect for in COVID Diagnostics?
  Corine Geurts van Kessel, MD PhD – Erasmus MC department of Viroscience